Sonoma Pharmaceuticals
(NASDAQ) SNOA
Sonoma Pharmaceuticals Financials at a Glance
Market Cap
$3.69M
Revenue (TTM)
$17.72M
Net Income (TTM)
$3.37M
EPS (TTM)
$-2.04
P/E Ratio
-1.05
Dividend
$0.00
Beta (Volatility)
1.11 (Average)
Dividend
$0.00
Beta (Volatility)
1.11 (Average)
Price
$2.41
Volume
824
Open
$2.31
Price
$2.41
Volume
824
Open
$2.31
Previous Close
$2.41
Daily Range
$2.31 - $2.53
52-Week Range
$1.75 - $6.92
Dividend
$0.00
Beta (Volatility)
1.11 (Average)
Price
$2.41
Volume
824
Open
$2.31
Previous Close
$2.41
Daily Range
$2.31 - $2.53
52-Week Range
$1.75 - $6.92
SNOA News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Sonoma Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
168
CEO
Amy M. Trombly
Website
www.sonomapharma.comHeadquarters
Woodstock, GA 30189, US
SNOA Financials
Key Financial Metrics (TTM)
Gross Margin
38%
Operating Margin
-16%
Net Income Margin
-19%
Return on Equity
-81%
Return on Capital
-29%
Return on Assets
-25%
Earnings Yield
-95.24%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$3.69M
Shares Outstanding
1.73M
Volume
824
Short Interest
0.00%
Avg. Volume
21.09K
Financials (TTM)
Gross Profit
$5.46M
Operating Income
$3.71M
EBITDA
$3.57M
Operating Cash Flow
$88.00K
Capital Expenditure
$80.00K
Free Cash Flow
$168.00K
Cash & ST Invst.
$5.37M
Total Debt
$305.00K
Sonoma Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$4.35M
+22.0%
Gross Profit
$1.65M
+29.9%
Gross Margin
37.94%
N/A
Market Cap
$3.69M
N/A
Market Cap/Employee
$368.62K
N/A
Employees
10
N/A
Net Income
$819.00K
+11.7%
EBITDA
$644.00K
+35.5%
Quarterly Fundamentals
Net Cash
$1.91M
-62.8%
Accounts Receivable
$2.38M
-1.0%
Inventory
$3.70M
+17.8%
Long Term Debt
$509.00K
+1655.2%
Short Term Debt
$146.00K
+62.2%
Return on Assets
-24.74%
N/A
Return on Invested Capital
-29.41%
N/A
Free Cash Flow
$811.00K
-347.3%
Operating Cash Flow
$764.00K
-315.8%